Advantage Alpha Capital Partners LP Collegium Pharmaceutical, Inc Transaction History
Advantage Alpha Capital Partners LP
- $361 Million
- Q1 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 19,161 shares of COLL stock, worth $600,888. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,161Holding current value
$600,888% of portfolio
0.16%Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$182 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$94.1 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.8 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$70.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$51.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.07B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...